- In July 2024, the Mayo Clinic reported that a multidisciplinary surgical approach using modified Mohs micrographic surgery significantly improved 3‑year recurrence‑free survival—93.3% vs. 65.9% for conventional wide local excision—in female genital EMPD
- In February 2024 study has identified FOXM1 as a promising therapeutic target in EMPD. Elevated FOXM1 expression correlated with disease progression, and inhibiting it with thiostrepton reduced tumor cell viability in vitro
